Compile Data Set for Download or QSAR
Report error Found 47 Enz. Inhib. hit(s) with all data for entry = 11767
TargetProtein O-GlcNAcase(Human)
Medifron Dbt

US Patent
LigandPNGBDBM50592032(CHEMBL5194370 | US20240018135, Code C-8)
Affinity DataIC50: 0nMAssay Description:Human OGA (recombinant hOGA protein, advanced Protein Technologies corp., Korea) enzyme reaction was performed in a reaction solution containing 25 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Medifron Dbt

US Patent
LigandPNGBDBM645669(US20240018135, Code A-34S)
Affinity DataIC50: 6.10nMAssay Description:Human OGA (recombinant hOGA protein, advanced Protein Technologies corp., Korea) enzyme reaction was performed in a reaction solution containing 25 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Medifron Dbt

US Patent
LigandPNGBDBM645643(N-([1,1'-biphenyl]-4-ylmethyl)- 2-(4-((2-acetamido...)
Affinity DataIC50: 30nMAssay Description:Human OGA (recombinant hOGA protein, advanced Protein Technologies corp., Korea) enzyme reaction was performed in a reaction solution containing 25 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Medifron Dbt

US Patent
LigandPNGBDBM50592008(CHEMBL5171168 | US20240018135, Code A-34)
Affinity DataIC50: 50nMAssay Description:Human OGA (recombinant hOGA protein, advanced Protein Technologies corp., Korea) enzyme reaction was performed in a reaction solution containing 25 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Medifron Dbt

US Patent
LigandPNGBDBM50592008(CHEMBL5171168 | US20240018135, Code A-34)
Affinity DataIC50: 50nMAssay Description:Human OGA (recombinant hOGA protein, advanced Protein Technologies corp., Korea) enzyme reaction was performed in a reaction solution containing 25 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Medifron Dbt

US Patent
LigandPNGBDBM645654(1-(benzo[d][1,3]dioxo]- 5-yl)ethyl 1-((2- acetamid...)
Affinity DataIC50: 60nMAssay Description:Human OGA (recombinant hOGA protein, advanced Protein Technologies corp., Korea) enzyme reaction was performed in a reaction solution containing 25 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Medifron Dbt

US Patent
LigandPNGBDBM50592013(CHEMBL5207537 | US20240018135, Code A-39)
Affinity DataIC50: 60nMAssay Description:Human OGA (recombinant hOGA protein, advanced Protein Technologies corp., Korea) enzyme reaction was performed in a reaction solution containing 25 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Medifron Dbt

US Patent
LigandPNGBDBM50592011(CHEMBL5178544 | US20240018135, Code A-37)
Affinity DataIC50: 70nMAssay Description:Human OGA (recombinant hOGA protein, advanced Protein Technologies corp., Korea) enzyme reaction was performed in a reaction solution containing 25 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Medifron Dbt

US Patent
LigandPNGBDBM50592031(CHEMBL5193589 | US20240018135, Code C-7)
Affinity DataIC50: 80nMAssay Description:Human OGA (recombinant hOGA protein, advanced Protein Technologies corp., Korea) enzyme reaction was performed in a reaction solution containing 25 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Medifron Dbt

US Patent
LigandPNGBDBM50592009(CHEMBL5185615 | US20240018135, Code A-35)
Affinity DataIC50: 100nMAssay Description:Human OGA (recombinant hOGA protein, advanced Protein Technologies corp., Korea) enzyme reaction was performed in a reaction solution containing 25 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Medifron Dbt

US Patent
LigandPNGBDBM50592027(CHEMBL5195515 | US20240018135, Code C-3)
Affinity DataIC50: 140nMAssay Description:Human OGA (recombinant hOGA protein, advanced Protein Technologies corp., Korea) enzyme reaction was performed in a reaction solution containing 25 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Medifron Dbt

US Patent
LigandPNGBDBM50592020(CHEMBL5174693 | US20240018135, Code B-15)
Affinity DataIC50: 160nMAssay Description:Human OGA (recombinant hOGA protein, advanced Protein Technologies corp., Korea) enzyme reaction was performed in a reaction solution containing 25 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Medifron Dbt

US Patent
LigandPNGBDBM50592026(CHEMBL5170611 | US20240018135, Code C-2)
Affinity DataIC50: 170nMAssay Description:Human OGA (recombinant hOGA protein, advanced Protein Technologies corp., Korea) enzyme reaction was performed in a reaction solution containing 25 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Medifron Dbt

US Patent
LigandPNGBDBM645642(N-([1.1'-biphenyl]-4-ylmethyl)- 2-(4-((2-acetamido...)
Affinity DataIC50: 210nMAssay Description:Human OGA (recombinant hOGA protein, advanced Protein Technologies corp., Korea) enzyme reaction was performed in a reaction solution containing 25 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Medifron Dbt

US Patent
LigandPNGBDBM50592028(CHEMBL5201343 | US20240018135, Code C-4)
Affinity DataIC50: 230nMAssay Description:Human OGA (recombinant hOGA protein, advanced Protein Technologies corp., Korea) enzyme reaction was performed in a reaction solution containing 25 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Medifron Dbt

US Patent
LigandPNGBDBM50592021(CHEMBL5185268 | US20240018135, Code B-16)
Affinity DataIC50: 230nMAssay Description:Human OGA (recombinant hOGA protein, advanced Protein Technologies corp., Korea) enzyme reaction was performed in a reaction solution containing 25 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Medifron Dbt

US Patent
LigandPNGBDBM50592007(CHEMBL5173570 | US20240018135, Code A-33)
Affinity DataIC50: 230nMAssay Description:Human OGA (recombinant hOGA protein, advanced Protein Technologies corp., Korea) enzyme reaction was performed in a reaction solution containing 25 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Medifron Dbt

US Patent
LigandPNGBDBM50592006(CHEMBL5208495 | US20240018135, Code A-32)
Affinity DataIC50: 240nMAssay Description:Human OGA (recombinant hOGA protein, advanced Protein Technologies corp., Korea) enzyme reaction was performed in a reaction solution containing 25 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Medifron Dbt

US Patent
LigandPNGBDBM50592023(CHEMBL5174507 | US20240018135, Code B-18)
Affinity DataIC50: 240nMAssay Description:Human OGA (recombinant hOGA protein, advanced Protein Technologies corp., Korea) enzyme reaction was performed in a reaction solution containing 25 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Medifron Dbt

US Patent
LigandPNGBDBM645653(1-((2-acetamidothiazol- 5-yl)methyl)-N-(1- (naphth...)
Affinity DataIC50: 250nMAssay Description:Human OGA (recombinant hOGA protein, advanced Protein Technologies corp., Korea) enzyme reaction was performed in a reaction solution containing 25 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Medifron Dbt

US Patent
LigandPNGBDBM50592017(CHEMBL5169359 | US20240018135, Code B-2)
Affinity DataIC50: 270nMAssay Description:Human OGA (recombinant hOGA protein, advanced Protein Technologies corp., Korea) enzyme reaction was performed in a reaction solution containing 25 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Medifron Dbt

US Patent
LigandPNGBDBM50592019(CHEMBL5177211 | US20240018135, Code B-14)
Affinity DataIC50: 300nMAssay Description:Human OGA (recombinant hOGA protein, advanced Protein Technologies corp., Korea) enzyme reaction was performed in a reaction solution containing 25 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Medifron Dbt

US Patent
LigandPNGBDBM50592025(CHEMBL5169931 | US20240018135, Code C-1)
Affinity DataIC50: 310nMAssay Description:Human OGA (recombinant hOGA protein, advanced Protein Technologies corp., Korea) enzyme reaction was performed in a reaction solution containing 25 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Medifron Dbt

US Patent
LigandPNGBDBM50592018(CHEMBL5169339 | US20240018135, Code B-6)
Affinity DataIC50: 320nMAssay Description:Human OGA (recombinant hOGA protein, advanced Protein Technologies corp., Korea) enzyme reaction was performed in a reaction solution containing 25 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Medifron Dbt

US Patent
LigandPNGBDBM50592022(CHEMBL5187979 | US20240018135, Code B-17)
Affinity DataIC50: 340nMAssay Description:Human OGA (recombinant hOGA protein, advanced Protein Technologies corp., Korea) enzyme reaction was performed in a reaction solution containing 25 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Medifron Dbt

US Patent
LigandPNGBDBM50592030(CHEMBL5178723 | US20240018135, Code C-6)
Affinity DataIC50: 350nMAssay Description:Human OGA (recombinant hOGA protein, advanced Protein Technologies corp., Korea) enzyme reaction was performed in a reaction solution containing 25 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Medifron Dbt

US Patent
LigandPNGBDBM50592012(CHEMBL5179931 | US20240018135, Code A-38)
Affinity DataIC50: 370nMAssay Description:Human OGA (recombinant hOGA protein, advanced Protein Technologies corp., Korea) enzyme reaction was performed in a reaction solution containing 25 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Medifron Dbt

US Patent
LigandPNGBDBM50592029(CHEMBL5202918 | US20240018135, Code C-5)
Affinity DataIC50: 450nMAssay Description:Human OGA (recombinant hOGA protein, advanced Protein Technologies corp., Korea) enzyme reaction was performed in a reaction solution containing 25 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Medifron Dbt

US Patent
LigandPNGBDBM50592024(CHEMBL5199464 | US20240018135, Code B-19)
Affinity DataIC50: 450nMAssay Description:Human OGA (recombinant hOGA protein, advanced Protein Technologies corp., Korea) enzyme reaction was performed in a reaction solution containing 25 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Medifron Dbt

US Patent
LigandPNGBDBM645626(2-(4-((2-acetamidothiazol-5- yl)methyl)piperazin-1...)
Affinity DataIC50: 630nMAssay Description:Human OGA (recombinant hOGA protein, advanced Protein Technologies corp., Korea) enzyme reaction was performed in a reaction solution containing 25 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Medifron Dbt

US Patent
LigandPNGBDBM50592016(CHEMBL5177251 | US20240018135, Code B-3)
Affinity DataIC50: 680nMAssay Description:Human OGA (recombinant hOGA protein, advanced Protein Technologies corp., Korea) enzyme reaction was performed in a reaction solution containing 25 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Medifron Dbt

US Patent
LigandPNGBDBM645652(1-((2-acetamidothiazol- 5-yl)methyl)-N-(1-(p-tol y...)
Affinity DataIC50: 830nMAssay Description:Human OGA (recombinant hOGA protein, advanced Protein Technologies corp., Korea) enzyme reaction was performed in a reaction solution containing 25 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Medifron Dbt

US Patent
LigandPNGBDBM50591999(CHEMBL5175161 | US20240018135, Code A-7)
Affinity DataIC50: 840nMAssay Description:Human OGA (recombinant hOGA protein, advanced Protein Technologies corp., Korea) enzyme reaction was performed in a reaction solution containing 25 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Medifron Dbt

US Patent
LigandPNGBDBM645649(1-((2-acetamidothiazol- 5-yl)methyl)-N-(4- methoxy...)
Affinity DataIC50: 860nMAssay Description:Human OGA (recombinant hOGA protein, advanced Protein Technologies corp., Korea) enzyme reaction was performed in a reaction solution containing 25 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Medifron Dbt

US Patent
LigandPNGBDBM50592014(CHEMBL5181336 | US20240018135, Code B-1)
Affinity DataIC50: 870nMAssay Description:Human OGA (recombinant hOGA protein, advanced Protein Technologies corp., Korea) enzyme reaction was performed in a reaction solution containing 25 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Medifron Dbt

US Patent
LigandPNGBDBM50592005(CHEMBL5197958 | US20240018135, Code A-22)
Affinity DataIC50: 900nMAssay Description:Human OGA (recombinant hOGA protein, advanced Protein Technologies corp., Korea) enzyme reaction was performed in a reaction solution containing 25 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Medifron Dbt

US Patent
LigandPNGBDBM645651(1-((2-acetamidothiazol- 5-yl)methyl)-N-(1- phenyle...)
Affinity DataIC50: 900nMAssay Description:Human OGA (recombinant hOGA protein, advanced Protein Technologies corp., Korea) enzyme reaction was performed in a reaction solution containing 25 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Medifron Dbt

US Patent
LigandPNGBDBM50592015(CHEMBL5205031 | US20240018135, Code B-7)
Affinity DataIC50: 1.00E+3nMAssay Description:Human OGA (recombinant hOGA protein, advanced Protein Technologies corp., Korea) enzyme reaction was performed in a reaction solution containing 25 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Medifron Dbt

US Patent
LigandPNGBDBM645650(1-((2-acetamidothiazol- 5-ylmethyl)-N-(1-(benzo [d...)
Affinity DataIC50: 1.01E+3nMAssay Description:Human OGA (recombinant hOGA protein, advanced Protein Technologies corp., Korea) enzyme reaction was performed in a reaction solution containing 25 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Medifron Dbt

US Patent
LigandPNGBDBM50592010(CHEMBL5200055 | US20240018135, Code A-36)
Affinity DataIC50: 1.04E+3nMAssay Description:Human OGA (recombinant hOGA protein, advanced Protein Technologies corp., Korea) enzyme reaction was performed in a reaction solution containing 25 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Medifron Dbt

US Patent
LigandPNGBDBM50592002(CHEMBL5183785 | US20240018135, Code A-14)
Affinity DataIC50: 1.25E+3nMAssay Description:Human OGA (recombinant hOGA protein, advanced Protein Technologies corp., Korea) enzyme reaction was performed in a reaction solution containing 25 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Medifron Dbt

US Patent
LigandPNGBDBM50592004(CHEMBL5199134 | US20240018135, Code A-20)
Affinity DataIC50: 1.40E+3nMAssay Description:Human OGA (recombinant hOGA protein, advanced Protein Technologies corp., Korea) enzyme reaction was performed in a reaction solution containing 25 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Medifron Dbt

US Patent
LigandPNGBDBM50592003(CHEMBL5189009 | US20240018135, Code A-15)
Affinity DataIC50: 1.40E+3nMAssay Description:Human OGA (recombinant hOGA protein, advanced Protein Technologies corp., Korea) enzyme reaction was performed in a reaction solution containing 25 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Medifron Dbt

US Patent
LigandPNGBDBM645629(2-(4-((2-acetamidothiazol-5- yl)methyljpiperazin-1...)
Affinity DataIC50: 1.70E+3nMAssay Description:Human OGA (recombinant hOGA protein, advanced Protein Technologies corp., Korea) enzyme reaction was performed in a reaction solution containing 25 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Medifron Dbt

US Patent
LigandPNGBDBM50592001(CHEMBL5183741 | US20240018135, Code A-12)
Affinity DataIC50: 1.99E+3nMAssay Description:Human OGA (recombinant hOGA protein, advanced Protein Technologies corp., Korea) enzyme reaction was performed in a reaction solution containing 25 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Medifron Dbt

US Patent
LigandPNGBDBM50591998(CHEMBL5190784 | US20240018135, Code A-1)
Affinity DataIC50: 2.60E+3nMAssay Description:Human OGA (recombinant hOGA protein, advanced Protein Technologies corp., Korea) enzyme reaction was performed in a reaction solution containing 25 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Medifron Dbt

US Patent
LigandPNGBDBM50592000(CHEMBL5192446 | US20240018135, Code A-11)
Affinity DataIC50: 2.61E+3nMAssay Description:Human OGA (recombinant hOGA protein, advanced Protein Technologies corp., Korea) enzyme reaction was performed in a reaction solution containing 25 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
Go to US Patent